Stock Report

Solara Active Pharma Sciences Ltd consolidated Q4 FY2023 net profit up at Rs. 3.77 crores

Posted On : 2023-05-12 17:48:44( TIMEZONE : IST )

Solara Active Pharma Sciences Limited has reported Consolidated financial results for the period ended March 31, 2023.

Financial Results (Q4 FY2023) - QoQ Comparison

The company has reported total income of Rs. 385.30 crores during the period ended March 31, 2023 as compared to Rs. 401.92 crores during the period ended December 31, 2022.

The company has posted net profit / (loss) of Rs. 3.77 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 0.45 crores for the period ended December 31, 2022.

The company has reported EPS of Rs. 1.05 for the period ended March 31, 2023 as compared to Rs. 0.12 for the period ended December 31, 2022.

Financials	Q4 FY2023	Q3 FY2023	% Change
Total Income	₹ 385.30 crs	₹401.92 crs	-4.14%
Net Profit	₹3.77 crs	₹0.45 crs	737.78%
EPS	₹1.05	₹0.12	775.00%

Financial Results (Q4 FY2023) - YoY Comparison

The company has reported total income of Rs. 385.30 crores during the period ended March 31, 2023 as compared to Rs.366.89 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs.3.77 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.1.88 crores for the period ended March 31, 2022.

The company has reported EPS of Rs.1.05 for the period ended March 31, 2023 as compared to Rs.0.53 for the period ended March 31, 2022.

Financials	Q4 FY2023	Q4 FY2022	% Change
Total Income	₹ 385.30 crs	₹366.89 crs	5.02%
Net Profit	₹3.77 crs	₹1.88 crs	100.53%
EPS	₹1.05	₹0.53	98.11%

Financial Results (Year Ended FY2023) - YoY Comparison

The company has reported total income of Rs.1466.36 crores during the Financial Year ended March 31, 2023 as compared to Rs.1288.36 crores during the Financial Year ended March 31, 2022.

The company has posted net profit / (loss) of Rs.-22.17 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.-58.15 crores for the Financial Year ended March 31, 2022.

The company has reported EPS of Rs.-6.16 for the Financial Year ended March 31, 2023 as compared to Rs.-16.18 for the Financial Year ended March 31, 2022.

Financials	Year Ended FY2023	Year Ended FY2022	% Change
Total Income	₹1466.36 crs	₹1288.36 crs	13.82%
Net Profit	₹-22.17 crs	₹-58.15 crs	61.87%
EPS	₹-6.16	₹-16.18	61.93%

Shares of Solara Active Pharma Sciences Limited was last trading in BSE at Rs. 411.45 as compared to the previous close of Rs. 380.25. The total number of shares traded during the day was 138848 in over 10049 trades.

The stock hit an intraday high of Rs. 430.00 and intraday low of 376.80. The net turnover during the day was Rs. 54748889.00.